Parkinson's Disease Trial, Not Yet Recruiting NCT05558189 Sponsor: Stanford University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT05558189
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 35 and 92 years old at the time of joining the trial.
  • People who have been diagnosed with idiopathic Parkinson's disease (a form of Parkinson's disease that does not have a known cause).
  • People who have had a surgical treatment for Parkinson's disease that does not involve Deep Brain Stimulation.
  • People who are fluent in English.
  • People who have adequate social support available if needed during an "off state" (a period when Parkinson's medication is less effective and symptoms are more noticeable).
  • People who are comfortable using technology, including computers, email, the internet, and video calls for training and check-ins.
  • People who live in the United States.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have significant psychiatric or neurological conditions, such as acute confusion, ongoing psychosis, or suicidal thoughts.
  • People who are currently misusing drugs or alcohol.
  • People who are currently taking part in, or have taken part in, another clinical trial involving a drug, device, or biological treatment within the last 30 days (any exceptions would need approval from the principal investigators).
  • People who are pregnant, breastfeeding, or planning to become pregnant.
  • People who are unable to communicate effectively with trial staff due to severe speech difficulties.
  • People who experience excessive drooling.
  • People who have abnormal sensation in their fingertips.
  • People who have received Deep Brain Stimulation treatment.
  • People whose Parkinson's disease symptoms are so severe that they are confined to bed.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

If you need support right now

This page includes language about suicide and self-harm, because that is how the trial's eligibility criteria are written. If reading it has been hard, you do not have to keep going. The services below are free, confidential, and answered by people trained for exactly this.

If you or someone else is in immediate danger, call 000.

  • Lifeline — 24/7 crisis support: 13 11 14
  • Suicide Call Back Service — 24/7 counselling: 1300 659 467
  • 13YARN — 24/7, for Aboriginal and Torres Strait Islander people: 13 92 76
  • Beyond Blue — 24/7 mental health support: 1300 22 4636
  • Emergency: 000

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention. If you are in immediate danger, call your local emergency number.

Voxsanity is not a crisis service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Contact this trial

Phone: 650-474-9547

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
20 August 2025
Est. completion
21 November 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Movement Disorders Society Unified Parkinson's Disease Rating Scale Part 3 (MDS-UPDRS III) change from baseline to 24 months.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov